Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43.

Kushimura Y, Tokuda T, Azuma Y, Yamamoto I, Mizuta I, Mizuno T, Nakagawa M, Ueyama M, Nagai Y, Yoshida H, Yamaguchi M.

Am J Neurodegener Dis. 2018 Feb 5;7(1):11-31. eCollection 2018.

2.

The protective effects of crocin in the management of neurodegenerative diseases: a review.

Farkhondeh T, Samarghandian S, Shaterzadeh Yazdi H, Samini F.

Am J Neurodegener Dis. 2018 Feb 5;7(1):1-10. eCollection 2018. Review.

3.

One case with dexmedetomidine-induced stuporous state in epileptic patient undergoing abdominal surgery.

Han DJ, He ZG, Zhou ZQ, Feng L, Liu C, Xiang Y, Xiang HB.

Am J Neurodegener Dis. 2017 Jul 25;6(3):26-31. eCollection 2017.

4.

Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Garcia-Esparcia P, Sideris-Lampretsas G, Hernandez-Ortega K, Grau-Rivera O, Sklaviadis T, Gelpi E, Ferrer I.

Am J Neurodegener Dis. 2017 Jun 15;6(2):15-25. eCollection 2017.

5.

Can levodopa prevent cognitive decline in patients with Parkinson's disease?

Ikeda M, Kataoka H, Ueno S.

Am J Neurodegener Dis. 2017 Jun 15;6(2):9-14. eCollection 2017.

6.

Etiology and treatment of amyotrophic lateral sclerosis.

Rafael H, David JO, Vilca AS.

Am J Neurodegener Dis. 2017 Apr 15;6(1):1-8. eCollection 2017.

7.

Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline.

Wang M, Norman JE, Srinivasan VJ, Rutledge JC.

Am J Neurodegener Dis. 2016 Nov 30;5(5):171-177. eCollection 2016. Review.

8.

Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab.

Roher AE, Maarouf CL, Kokjohn TA, Belden C, Serrano G, Sabbagh MS, Beach TG.

Am J Neurodegener Dis. 2016 Aug 26;5(4):158-170. eCollection 2016.

9.

Omental transplantation in a patient with mild ALS.

Rafael H.

Am J Neurodegener Dis. 2016 Jul 6;5(3):153-7. eCollection 2016.

10.
11.

Effect of fish oil on glutathione redox system in multiple sclerosis.

Sorto-Gomez TE, Ortiz GG, Pacheco-Moises FP, Torres-Sanchez ED, Ramirez-Ramirez V, Macias-Islas MA, de la Rosa AC, Velázquez-Brizuela IE.

Am J Neurodegener Dis. 2016 Jun 1;5(2):145-51. eCollection 2016.

13.
14.

The presenilin 1 p.Gly206Ala mutation is a frequent cause of early-onset Alzheimer's disease in Hispanics in Florida.

Ravenscroft TA, Pottier C, Murray ME, Baker M, Christopher E, Levitch D, Brown PH, Barker W, Duara R, Greig-Custo M, Betancourt A, English M, Sun X, Ertekin-Taner N, Graff-Radford NR, Dickson DW, Rademakers R.

Am J Neurodegener Dis. 2016 Mar 1;5(1):94-101. eCollection 2016.

15.

Association study between the DNMT3A -448A>G polymorphism and risk of Alzheimer's disease in Caucasians of Italian origin.

Tannorella P, Stoccoro A, Tognoni G, Bonuccelli U, Migliore L, Coppedè F.

Am J Neurodegener Dis. 2016 Mar 1;5(1):85-93. eCollection 2016.

16.

Molecular events linking cholesterol to Alzheimer's disease and inclusion body myositis in a rabbit model.

Liu QY, Koukiekolo R, Zhang DL, Smith B, Ly D, Lei JX, Ghribi O.

Am J Neurodegener Dis. 2016 Mar 1;5(1):74-84. eCollection 2016.

17.
18.
19.

Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson's disease.

Zhang X, Wang Y, Ma C, Yan Y, Yang Y, Wang X, Rausch WD.

Am J Neurodegener Dis. 2016 Mar 1;5(1):52-61. eCollection 2016.

20.

Supplemental Content

Loading ...
Support Center